OBERLAND CAPITAL
Oberland Capital provides innovative financing solutions to companies and royalty holders in the healthcare industry. We specialize in flexible investment structures customized to meet the specific capital requirements and strategic objectives of transaction partners globally. Our broad suite of financing solutions includes monetization of royalty streams, acquisition of future product revenues, creation of project-based financing structures, and investment in debt and equity securities. With a combination of deep industry knowledge and extensive structured finance experience, the Oberland Capital team has a history of creating value for our transaction partners.
OBERLAND CAPITAL
Industry:
Asset Management Financial Services Venture Capital
Founded:
2013-01-01
Status:
Active
Contact:
212-257-5850
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Analytics Content Delivery Network Google Universal Analytics Font Awesome Mobile Non Scaleable Content Sitelinks Search Box Google Maps
Similar Organizations
Equinox Capital
Equinox Capital provides its services to investment companies.
FlatWorld Capital
FlatWorld Capital provides financing solutions to middle-market companies.
Tahoma Ventures
Tahoma Ventures provides early stage capital to IT technology startups.
Third Eye Capital
Third Eye Capital provides innovative and customized lending solutions for companies.
TMT Investments
TMT Investments provides investors with liquid exposure to a diversified portfolio of earlier-stage technology startups.
Current Employees Featured
Jean-Pierre Naegeli Managing Partner & FOUNDER @ Oberland Capital
Managing Partner & FOUNDER
Cecilia Gonzalo Partner @ Oberland Capital
Partner
2018-10-01
Michael Bloom Partner @ Oberland Capital
Partner
2018-11-01
William Clifford Partner @ Oberland Capital
Partner
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-12-14 | Zealand Pharma | Oberland Capital investment in Post-IPO Debt - Zealand Pharma | 200 M USD |
| 2021-10-04 | Centessa Pharmaceuticals | Oberland Capital investment in Post-IPO Debt - Centessa Pharmaceuticals | 300 M USD |
| 2021-04-26 | Esperion | Oberland Capital investment in Post-IPO Equity - Esperion | 50 M USD |
| 2020-12-09 | Mirum Pharmaceuticals | Oberland Capital investment in Post-IPO Equity - Mirum Pharmaceuticals | 10 M USD |
| 2020-10-27 | Primmune Therapeutics | Oberland Capital investment in Series A - Primmune Therapeutics | 27.4 M USD |
| 2019-04-23 | NorthStar Medical Radioisotopes | Oberland Capital investment in Venture Round - NorthStar Medical Radioisotopes | 75 M USD |
| 2017-10-26 | Impact Biomedicines | Oberland Capital investment in Debt Financing - Impact Biomedicines | 90 M USD |
| 2017-06-29 | Melinta Therapeutics | Oberland Capital investment in Post-IPO Equity - Melinta Therapeutics | 90 M USD |
More informations about "Oberland Capital"
About - Oberland Capital
Founded in 2013, Oberland Capital is a dedicated healthcare investment firm with approximately $3.2 billion in assets under management. We specialize in flexible investment structures for …See details»
Team - Oberland Capital
The Oberland Capital investment team has over 200 years of combined relevant healthcare and investment experience. We possess significant scientific, operational, and financial expertise …See details»
Oberland Capital - Crunchbase Investor Profile
Oberland Capital provides innovative financing solutions to companies and royalty holders in the healthcare industry. We specialize in flexible investment structures customized to meet the specific capital requirements and strategic objectives …See details»
Oberland Capital - LinkedIn
Oberland Capital is a private investment firm formed in 2013 with assets under management in excess of $3 billion, focused exclusively on investing in the global healthcare industry and ...See details»
Oberland Capital Company Profile: Financings & Team
Oberland Capital is an investment firm which provides innovative financing solutions for healthcare companies and royalty holders. The firm offers a broad suite of financing solutions including the monetization of royalty streams, …See details»
Oberland Capital - Investor in New York, New York - Ask For Funding
Oberland Capital is a private investment firm committed to funding innovation across the global healthcare industry. With approximately $3.2 billion in assets under management, Oberland …See details»
Oberland Capital - The Org
Oberland Capital provides innovative financing solutions to companies and royalty holders in the healthcare industry. They specialize in flexible investment structures customized to meet the specific capital requirements and strategic …See details»
Biohaven lands funding Oberland funding deal worth …
3 days ago Oberland Capital Management is pumping some new life into Biohaven, striking a unique investment deal worth up to $600 million as the biotech awaits a key FDA approval decision that could propel ...See details»
Oberland Capital Company Profile | Management and Employees …
Oberland Capital Profile and History. Oberland Capital, a private investment firm with over $2.25 billion in capital commitments since inception, is focused exclusively on investing in the global …See details»
Oberland Capital - Investments, Portfolio & Company Exits
Oberland Capital provides innovative financing solutions to companies . Verastem Oncology Verastem is a biopharmaceutical company developing new medicines to improve the lives of …See details»
Strategy - Oberland Capital
Oberland Capital’s broad suite of flexible financing solutions includes monetization of royalty streams, acquisition of future product revenues, creation of project-based financing structures, …See details»
Oberland Capital - teaserclub.com
Oberland Capital We specialize in flexible investment structures customized to meet the specific capital requirements and strategic objectives of transaction partners globally. Our broad suite …See details»
Oberland Capital | Institution Profile - Private Equity International
Oberland Capital News, insights, analysis and data Founded in 2013, Oberland Capital is an New York-based investment firm that targets the healthcare industry across the globe.See details»
Oberland Capital – Investors Database - Unicorn Nest
Oberland Capital appeared to be the VC, which was created in 2013. The leading representative office of defined VC is situated in the New York. The venture was found in North America in …See details»
Oberland Capital's Leadership Team - Team members and org …
The leadership team at Oberland Capital has a wide range of experience in many different industries. Some members have experience in investment banking, while others come from a …See details»
Biohaven Announces Investment up to $600 Million by Oberland …
3 days ago Oberland Capital is a private investment firm formed in 2013 with assets under management in excess of $3.0 billion, focused exclusively on investing in the global healthcare …See details»
News - Oberland Capital
Oct 13, 2023 Oberland Capital Raises $1.05 Billion Healthcare Royalty Fund to Invest in Companies Advancing Products in Late-Stage Clinical Development April 23, 2019 NorthStar …See details»
Fundopedia | Oberland Capital
Oberland Capital is a private investment firm committed to funding innovation across the global healthcare industry. With approximately $3.5 billion in assets under management, Oberland …See details»
Biohaven Ltd Receives $600 Million Investment from Oberland …
3 days ago Under the terms of the NPA, Oberland Capital will have a right to receive a regulatory approval milestone payment, payable quarterly through Dec. 31, 2030, and tiered …See details»
Biohaven Announces Investment by Oberland Capital
2 days ago The investment from Oberland Capital takes the form of a Note Purchase Agreement (NPA) that is non-dilutive to current investors. The first tranche of $250 million of gross …See details»